640 related articles for article (PubMed ID: 12778332)
1. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease.
Borza DB; Hudson BG
Springer Semin Immunopathol; 2003 May; 24(4):345-61. PubMed ID: 12778332
[TBL] [Abstract][Full Text] [Related]
2. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen.
Wang XP; Fogo AB; Colon S; Giannico G; Abul-Ezz SR; Miner JH; Borza DB
J Am Soc Nephrol; 2005 Dec; 16(12):3563-71. PubMed ID: 16236801
[TBL] [Abstract][Full Text] [Related]
3. Circulating anti-glomerular basement membrane autoantibodies against α3(IV)NC1 undetectable by commercially available enzyme-linked immunosorbent assays.
Jia XY; Qu Z; Cui Z; Yang R; Zhao J; Zhao MH
Nephrology (Carlton); 2012 Feb; 17(2):160-6. PubMed ID: 21854504
[TBL] [Abstract][Full Text] [Related]
4. Natural anti-GBM antibodies from normal human sera recognize alpha3(IV)NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM disease.
Yang R; Cui Z; Hellmark T; Segelmark M; Zhao MH; Wang HY
Clin Immunol; 2007 Aug; 124(2):207-12. PubMed ID: 17556023
[TBL] [Abstract][Full Text] [Related]
5. Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease.
Yang R; Hellmark T; Zhao J; Cui Z; Segelmark M; Zhao MH; Wang HY
Nephrol Dial Transplant; 2009 Jun; 24(6):1838-44. PubMed ID: 19151145
[TBL] [Abstract][Full Text] [Related]
6. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis.
Pedchenko V; Bondar O; Fogo AB; Vanacore R; Voziyan P; Kitching AR; Wieslander J; Kashtan C; Borza DB; Neilson EG; Wilson CB; Hudson BG
N Engl J Med; 2010 Jul; 363(4):343-54. PubMed ID: 20660402
[TBL] [Abstract][Full Text] [Related]
7. Advances in the pathogenesis of Goodpasture's disease: from epitopes to autoantibodies to effector T cells.
Ooi JD; Holdsworth SR; Kitching AR
J Autoimmun; 2008 Nov; 31(3):295-300. PubMed ID: 18502098
[TBL] [Abstract][Full Text] [Related]
8. Quaternary organization of the goodpasture autoantigen, the alpha 3(IV) collagen chain. Sequestration of two cryptic autoepitopes by intrapromoter interactions with the alpha4 and alpha5 NC1 domains.
Borza DB; Bondar O; Todd P; Sundaramoorthy M; Sado Y; Ninomiya Y; Hudson BG
J Biol Chem; 2002 Oct; 277(42):40075-83. PubMed ID: 12193605
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to α5 chain of collagen IV are pathogenic in Goodpasture's disease.
Cui Z; Zhao MH; Jia XY; Wang M; Hu SY; Wang SX; Yu F; Brown KL; Hudson BG; Pedchenko V
J Autoimmun; 2016 Jun; 70():1-11. PubMed ID: 27117167
[TBL] [Abstract][Full Text] [Related]
10. Nasal administration of recombinant rat alpha3(IV)NC1 prevents the development of experimental autoimmune glomerulonephritis in the WKY rat.
Reynolds J; Prodromidi EI; Juggapah JK; Abbott DS; Holthaus KA; Kalluri R; Pusey CD
J Am Soc Nephrol; 2005 May; 16(5):1350-9. PubMed ID: 15814836
[TBL] [Abstract][Full Text] [Related]
11. Antigen and epitope specificity of anti-glomerular basement membrane antibodies in patients with goodpasture disease with or without anti-neutrophil cytoplasmic antibodies.
Yang R; Hellmark T; Zhao J; Cui Z; Segelmark M; Zhao MH; Wang HY
J Am Soc Nephrol; 2007 Apr; 18(4):1338-43. PubMed ID: 17329569
[TBL] [Abstract][Full Text] [Related]
12. The non-collagenous domains of the alpha 3 and 4 chains of type IV collagen and their relationship to the Goodpasture antigen.
Savige JA; Gallicchio M
Clin Exp Immunol; 1991 Jun; 84(3):454-8. PubMed ID: 2044225
[TBL] [Abstract][Full Text] [Related]
13. Autoepitopes and alloepitopes of type IV collagen: role in the molecular pathogenesis of anti-GBM antibody glomerulonephritis.
Borza DB
Nephron Exp Nephrol; 2007; 106(2):e37-43. PubMed ID: 17570938
[TBL] [Abstract][Full Text] [Related]
14. A nephritogenic peptide induces intermolecular epitope spreading on collagen IV in experimental autoimmune glomerulonephritis.
Chen L; Hellmark T; Pedchenko V; Hudson BG; Pusey CD; Fox JW; Bolton WK
J Am Soc Nephrol; 2006 Nov; 17(11):3076-81. PubMed ID: 17005930
[TBL] [Abstract][Full Text] [Related]
15. Goodpasture antigen: expression of the full-length alpha3(IV) chain of collagen IV and localization of epitopes exclusively to the noncollagenous domain.
Leinonen A; Netzer KO; Boutaud A; Gunwar S; Hudson BG
Kidney Int; 1999 Mar; 55(3):926-35. PubMed ID: 10027929
[TBL] [Abstract][Full Text] [Related]
16. High affinity of anti-GBM antibodies from Goodpasture and transplanted Alport patients to alpha3(IV)NC1 collagen.
Rutgers A; Meyers KE; Canziani G; Kalluri R; Lin J; Madaio MP
Kidney Int; 2000 Jul; 58(1):115-22. PubMed ID: 10886555
[TBL] [Abstract][Full Text] [Related]
17. Allograft rejection and glomerular basement membrane antibodies in Alport's syndrome.
Charytan D; Torre A; Khurana M; Nicastri A; Stillman IE; Kalluri R
J Nephrol; 2004; 17(3):431-5. PubMed ID: 15365966
[TBL] [Abstract][Full Text] [Related]
18. Distribution of familial nephritis antigen in normal tissue and renal basement membranes of patients with homozygous and heterozygous Alport familial nephritis. Relationship of familial nephritis and Goodpasture antigens to novel collagen chains and type IV collagen.
Kleppel MM; Kashtan C; Santi PA; Wieslander J; Michael AF
Lab Invest; 1989 Sep; 61(3):278-89. PubMed ID: 2671490
[TBL] [Abstract][Full Text] [Related]
19. Epitope spreading and autoimmune glomerulonephritis in rats induced by a T cell epitope of Goodpasture's antigen.
Bolton WK; Chen L; Hellmark T; Wieslander J; Fox JW
J Am Soc Nephrol; 2005 Sep; 16(9):2657-66. PubMed ID: 16049074
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of type IV collagen subchains in the glomerular basement membrane of patients with Alport syndrome with confocal microscopy.
Su J; Liu ZH; Zeng CH; Wei-Gong ; Chen HP; Li LS
Nephrol Dial Transplant; 2006 Jul; 21(7):1838-47. PubMed ID: 16574687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
